🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
0.6138
-0.0180 (-2.85%)
At close: Nov 19, 2026, 4:00 PM EST
0.6260
+0.0122 (1.99%)
After-hours: Nov 19, 2026, 7:45 PM EST

Metagenomi Therapeutics Revenue

Metagenomi Therapeutics had revenue of $2.18M in the quarter ending September 30, 2026, a decrease of -74.78%. This brings the company's total for the last twelve months to $7.09M, down -77.08% year-over-year. In the year 2025, Metagenomi Therapeutics had annual revenue of $25.21M, down -51.79%. That makes Metagenomi Therapeutics the 38,770th largest company in the world by revenue and 5,100th in the United States.

Revenue (ttm)
$7.09M
Revenue Growth
-77.08%
P/S Ratio
3.26
Revenue / Employee
$66,224
Employees
107
Market Cap
23.21M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202525.21M-27.09M-51.79%
Dec 31, 202452.30M7.54M16.84%
Dec 31, 202344.76M27.56M160.21%
Dec 31, 202217.20M16.96M6,978.19%
Dec 31, 2021243.00K--